Clinical Study
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
Table 2
Mean %EWL and %TWL at 12, 15, and 18 months in ITT population.
| Measure Visit month | Mean (95% CI) |
Difference (95% CI) | vBloc | Sham control | | |
| %EWL | | | | 12 months | 25.8 (23.2, 28.4) | 16.9 (13.1, 20.7) | 8.9 (4.3, 13.5) | 15 months | 24.4 (21.7, 27.2) | 12.9 (9.0, 16.9) | 11.5 (6.7, 16.3) | 18 months | 23.5 (20.8, 26.3) | 10.2 (6.0, 14.4) | 13.4 (8.4, 18.4) | %TWL | | | | 12 months | 9.7 (8.7, 10.7) | 6.4 (4.9, 7.8) | 3.3 (1.6, 5.0) | 15 months | 9.1 (8.1, 10.1) | 4.9 (3.4, 6.4) | 4.2 (2.4, 6.0) | 18 months | 8.8 (7.8, 9.8) | 3.8 (2.2, 5.4) | 5.0 (3.1, 6.9) |
|
|